approval
saveIBANDRONATE SODIUM — FDA approval
community read0 votes
Sponsor: MACLEODS PHARMS LTD. Form: TABLET. Route: ORAL
view source ↗Data sources
last refreshed 5mo ago
Found something off?
drug timeline · 8
- approvalIBANDRONATE SODIUM — FDA approvalFeb 3, 2026 · 249d ago
- approvalIBANDRONATE SODIUM — FDA approvalFeb 3, 2026 · 249d ago
- approvalIBANDRONATE SODIUM — FDA approvalFeb 3, 2026 · 249d ago
- approvalIBANDRONATE SODIUM — FDA approvalFeb 3, 2026 · 249d ago
- approvalIBANDRONATE SODIUM — FDA approvalFeb 3, 2026 · 249d ago
- approvalIBANDRONATE SODIUM — FDA approvalFeb 3, 2026 · 249d ago
- approvalIBANDRONATE SODIUM — FDA approvalFeb 3, 2026 · 249d ago
- approvalIBANDRONATE SODIUM — FDA approvalFeb 3, 2026 · 249d ago
same company · ±60 days · 6
- approvalolanzapine ODT: OLANZAPINE — FDA approvalJun 7, 2023
- approvalacetaminophen ER: TRAMADOL HYDROCHLORIDE AND ACETAMINOPHEN (ACETAMINOPHEN) — FDA approvalJun 7, 2023
- approvaltramadol hydrochloride ER: TRAMADOL HYDROCHLORIDE — FDA approvalJun 7, 2023
- approvalolanzapine ODT: OLANZAPINE — FDA approvalJun 7, 2023
- approvalALDACTAZIDE: LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE (HYDROCHLOROTHIAZIDE) — FDA approvalJun 7, 2023
- approvalALDACTAZIDE: OLMESARTAN MEDOXOMIL AND HYDROCHLOROTHIAZIDE (HYDROCHLOROTHIAZIDE) — FDA approvalJun 1, 2023
comments(0)
5-min edit window · permanent after that